image
Fate Therapeutics, Inc. FATE
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.08
-0.935 %
$ 124 M
Market Cap
-0.71
P/E
Price Target Average
301.23%
Revenue Forecast Estimate
30.52%
EBIT Estimate
34.14%
Net Income Estimate
3.80%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Fate Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for FATE of $4.33 , with forecasts ranging from a low of $3 to a high of $5 .
FATE Lowest Price Target Wall Street Target
3 USD 177.78%
FATE Average Price Target Wall Street Target
4.33 USD 301.23%
FATE Highest Price Target Wall Street Target
5 USD 362.96%
Price
Max Price Target
Min Price Target
Average Price Target
55554444333322221111Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25May '25May '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26May '26May '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart FATE

image
$100.0m$100.0m$90.0m$90.0m$80.0m$80.0m$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart FATE

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart FATE

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029